Across TCGA pan-cancer cohorts, OR7E41P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of OR7E41P’s most consistent transcriptional readouts.
The strongest signal is observed in stomach adenocarcinoma (STAD), where OR7E41P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR7E41P is over-expressed in tumor.
STAD are the cancer types where OR7E41P tumor–normal differential expression is most reproducible.